What is Protara Therapeutics, Inc. Common Stock's Market Cap?

Protara Therapeutics, Inc. Common Stock's Market Cap is $229.6M, based on as-reported figures from SEC (XBRL) filings.

What is Protara Therapeutics, Inc. Common Stock's Net Income (TTM)?

Protara Therapeutics, Inc. Common Stock's Net Income (TTM) is -$70.0M, based on as-reported figures from SEC (XBRL) filings.

What is Protara Therapeutics, Inc. Common Stock's EBITDA?

Protara Therapeutics, Inc. Common Stock's EBITDA is -$76.4M, based on as-reported figures from SEC (XBRL) filings.

What is Protara Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Protara Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.18, based on as-reported figures from SEC (XBRL) filings.

Protara Therapeutics, Inc. Common Stock (TARA) Financial Statements

Protara Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001ZLYSK1

XNAS · usd

3.89▼ 0.01 (-0.13%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close3.89

Day's Range3.83 – 3.96

52-Week Range3.02 – 7.82

Volume385.2K

Avg Volume359.3K

Share Statistics

Shares Outstanding

Employees51

ExchangeXNAS

Listed2020-01-10

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Protara Therapeutics, Inc. Common Stock (TARA)

What is Protara Therapeutics, Inc. Common Stock's Market Cap?: Protara Therapeutics, Inc. Common Stock's Market Cap is $229.6M, based on as-reported figures from SEC (XBRL) filings.
What is Protara Therapeutics, Inc. Common Stock's Net Income (TTM)?: Protara Therapeutics, Inc. Common Stock's Net Income (TTM) is -$70.0M, based on as-reported figures from SEC (XBRL) filings.
What is Protara Therapeutics, Inc. Common Stock's EBITDA?: Protara Therapeutics, Inc. Common Stock's EBITDA is -$76.4M, based on as-reported figures from SEC (XBRL) filings.
What is Protara Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Protara Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.18, based on as-reported figures from SEC (XBRL) filings.